ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Moffitt scientists discover new applications for Novartis's Zykadia
pharmafile
October 12, 2017Researchers at Moffitt screened 240 FDA-approved treatments as well as those currently in development to identify potential alternative uses. -
Novartis Drug Zykadia Receives FDA Priority Review for First-Line Use in Patients with ALK+ Metastat
americanpharmaceuticalreview
February 24, 2017Novartis announced that the US Food and Drug Administration (FDA) accepted the Company's supplemental New Drug Application (sNDA) for filing, and granted Priority Review for the expanded use of Zykadia? (ceritinib) as a first-line treatment for patients w
Pharma Sources Insight January 2025
